Treatment depends on the type of hyperparathyroidism encountered. Primary People with primary hyperparathyroidism who are symptomatic benefit from parathyroidectomy—surgery to remove the parathyroid tumor (parathyroid adenoma). Indications for surgery are: * Symptomatic hyperparathyroidism * Asymptomatic hyperparathyroidism with any of the following: * 24-hour urinary calcium > 400 mg (see footnote, below) * serum calcium > 1 mg/dl above upper limit of normal * Creatinine clearance > 30% below normal for patient's age * Bone density > 2.5 standard deviations below peak (i.e., T-score of -2.5) * People age < 50 Surgery can rarely result in hypoparathyroidism. Secondary In people with secondary hyperparathyroidism, the high PTH levels are an appropriate response to low calcium and treatment must be directed at the underlying<unk>  of this (usually vitamin D deficiency or chronic kidney failure). If this is successful, PTH levels return to normal levels, unless PTH secretion has become autonomous (tertiary hyperparathyroidism). Calcimimetics A calcimimetic (such as cinacalcet) is a potential therapy for some people with severe hypercalcemia and primary hyperparathyroidism who are unable to undergo parathyroidectomy, and for secondary hyperparathyroidism on dialysis. Treatment of secondary hyperparathyroidism with a calcimimetic in those on dialysis for CKD does not alter the risk of early death; however, it does decrease the likelihood of needing a parathyroidectomy. Treatment carries the risk of low blood calcium levels and vomiting.
medical cause of Osteitis fibrosa cystica
symptom of Osteitis fibrosa cystica
medical cause of Osteoarthritis
complications of Fibrous dysplasia of bone
complications of Osteomyelitis
complications of Bunion
complications of Patellar dislocation
complications of Repetitive strain injury